Leah O'brien
About Leah O'brien
Leah O'Brien is a Senior Medical Science Liaison at Prothena Corporation plc in Europe, with a background in medical advisory roles at various healthcare companies. She holds a PhD in Neuro-Immunology and Gastrointestinal Inflammation from University College Dublin and has extensive experience in oncology and clinical partnerships.
Current Role at Prothena Corporation
Leah O'Brien serves as the Senior Medical Science Liaison for the European region at Prothena Corporation plc. She has been in this role since 2022, contributing her expertise in medical science and communication within the organization. Her responsibilities include engaging with healthcare professionals and providing scientific information to support the company's therapeutic areas.
Previous Experience in the Pharmaceutical Industry
Before joining Prothena, Leah O'Brien held several significant positions in the pharmaceutical industry. She worked at Pfizer Healthcare Ireland as a Medical Advisor from 2010 to 2015, where she focused on medical affairs in Dublin. Following this, she served as a Medical Advisor in Oncology at Novartis Ireland Ltd for a brief period in 2015. Additionally, she was the Director of Clinical Partnerships in Oncology at Genomics Medicine Ireland from 2018 to 2019.
Educational Background in Medical Sciences
Leah O'Brien has an extensive educational background in medical sciences. She earned her Bachelor of Science degree in Cell Biology and Molecular Genetics from University College Dublin, completing her studies from 1996 to 2000. She furthered her education at Trinity College Dublin, obtaining a Postgraduate Diploma in Pharmaceutical Medicine between 2009 and 2011. Leah achieved her PhD in Neuro-Immunology and Gastrointestinal Inflammation at University College Dublin from 2001 to 2005.
Leadership Roles in Clinical Partnerships
Leah O'Brien has held leadership roles in clinical partnerships, particularly at Genomics Medicine Ireland. She worked as the Clinical Partnerships Leader from 2017 to 2018, where she was involved in developing strategic partnerships to enhance clinical research initiatives. Her role as Director of Clinical Partnerships in Oncology from 2018 to 2019 further solidified her expertise in this area.